Kura Oncology

KURA

9.3104.26% ( +0.380 )

Closed: Jul 30, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Kura Oncology(KURA) predict that the Revenue is 18.27 M (+29.47%), Miss estimate;the EBIT is -78.82 M (-21.82%), Miss estimate;the EPS is -0.83 (-25.76%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.02B29.47%

0.03B83.72%

-0.01B54.25%

EBITMiss expectations

-0.08B21.82%

-0.08B17.19%

-0.00B4.63%

EPSMiss expectations

-0.8325.76%

-0.824424.91%

-0.00560.85%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD